Bountiful Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 101.75%
- Profit Growth 44.12%
- Ebitda 160.78%
- Net Worth 28.62%
- Total Assets 79.10%
About Bountiful Lifesciences
Bountiful Lifesciences Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2014 and has a history of Ten years and eight months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹4.00 M.
Neetu Rani, Indra Singh, and Amita Sharma serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100UP2014PTC064249
- Company No.
064249
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Bountiful Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neetu Rani  | Director | 10-Jun-2014 | Current |
| Indra Singh | Director | 16-Mar-2020 | Current |
| Amita Sharma | Director | 06-Aug-2021 | Current |
Financial Performance of Bountiful Lifesciences.
Bountiful Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.75% increase. The company also saw a substantial improvement in profitability, with a 44.12% increase in profit. The company's net worth Soared by an impressive increase of 28.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bountiful Lifesciences?
In 2021, Bountiful Lifesciences had a promoter holding of 47.00% and a public holding of 53.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Exa Mendy Lab Private LimitedIndra Singh and Amita Sharma are mutual person
Charges (Loans)
Open Charges
₹4.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2023 | Others | ₹4.00 M | Open |
How Many Employees Work at Bountiful Lifesciences?
Bountiful Lifesciences has a workforce of 49 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bountiful Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bountiful Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
